32 results on '"Kurzer, Jason H."'
Search Results
2. TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML
3. Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology Group
4. Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group
5. Post-therapy Marrow Changes
6. Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology group
7. Acute Leukemias of Ambiguous Lineage: Clarification on Lineage Specificity
8. Updates in molecular genetics of acute myeloid leukemia
9. Supplementary data from E2A-PBX1 Remodels Oncogenic Signaling Networks in B-cell Precursor Acute Lymphoid Leukemia
10. Data from E2A-PBX1 Remodels Oncogenic Signaling Networks in B-cell Precursor Acute Lymphoid Leukemia
11. NPM1 mutations may be associated with adverse outcome in the setting of myeloid neoplasms with complex karyotype
12. Visceral leishmaniasis in the differential diagnosis of pancytopenia
13. To B‐ or not to B‐: A review of lineage switched acute leukemia
14. Growth Hormone Induced Activation and Regulation of JAK2 and STAT Proteins
15. PHF6 Mutations in Hematologic Malignancies
16. SH2B1 (SH2-B) and JAK2: a multifunctional adaptor protein and kinase made for each other
17. Capillary electrophoresis and fluorescence anisotropy for quantitative analysis of peptide--protein interactions using JAK2 and SH2.B[beta] as a model system
18. Erratum to: Growth Hormone Induced Activation and Regulation of JAK2 and STAT Proteins
19. TP53mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML
20. Clinical, Immunophenotypic and Genomic Findings of Acute Undifferentiated Leukemia and Comparison to AML with Minimal Differentiation: A Study from the Bone Marrow Pathology Group
21. Flow immunophenotyping of benign lymph nodes sampled by FNA: Representative with diagnostic pitfalls
22. Identification of early B cell precursors (stage 1 and 2 hematogones) in the peripheral blood
23. SETDB2 Links E2A-PBX1 to Cell-Cycle Dysregulation in Acute Leukemia through CDKN2C Repression
24. E2A-PBX1 Remodels Oncogenic Signaling Networks in B-cell Precursor Acute Lymphoid Leukemia
25. A replicable CD271+ mesenchymal stromal cell density score: bringing the dysfunctional myelodysplastic syndrome niche to the diagnostic laboratory
26. Mesenchymal Stromal Cell Density Is Increased in Higher Grade Myelodysplastic Syndromes and Independently Predicts Survival
27. Binding of SH2-B Family Members within a Potential Negative Regulatory Region Maintains JAK2 in an Active State
28. Capillary Electrophoresis and Fluorescence Anisotropy for Quantitative Analysis of Peptide−Protein Interactions Using JAK2 and SH2-Bβ as a Model System
29. Tyrosine 813 Is a Site of JAK2 Autophosphorylation Critical for Activation of JAK2 by SH2-Bβ
30. A replicable CD271+ mesenchymal stromal cell density score: bringing the dysfunctional myelodysplastic syndrome niche to the diagnostic laboratory.
31. Capillary Electrophoresis and Fluorescence Anisotropy for Quantitative Analysis of Peptide-Protein lnteractions Using JAK2 and SH2-Bβ as a Model System.
32. Capillary electrophoresis and fluorescence anisotropy for quantitative analysis of peptide-protein interactions using JAK2 and SH2-Bbeta as a model system.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.